Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Eosinophil; Eosinophil granule proteins; Eosinophil-related cutaneous disease; Eosinophil-related dermatoses; Eosinophilic cellulitis; Eosinophilic spongiosis; Skin disease; ALHE; Angiolymphoid hyperplasia with eosinophilia; CCL; C-C motif ligand; CCR3; C
مقالات ISI واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Human leukocyte antigen; T-cell receptor; Adverse drug reaction; Pharmacogenomics; Human herpes virus; Drug reaction with eosinophilia and systemic symptoms; Steven Johnson syndrome; Toxic epidermal necrolysis;
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Allergy; Drug reactions; Steven-Johnson syndrome; Toxic epidermal necrolysis; AA-cADR; Antibiotic-associated cutaneous adverse drug reactions; AGEP; Acute generalized exanthematous pustulosis; BSA; Body surface area; cADR; Cutaneous adverse drug reaction;
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Cutaneous adverse drug reactions; Urticaria/angioedema; Stevens–Johnson syndrome/toxic epidermal necrolysis; Acute generalized exanthematous pustulosis; Drug reaction with eosinophilia and systemic symptoms; Vasculitis
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; complication; corticosteroid; drug-induced hypersensitivity syndrome; drug reaction; drug reaction with eosinophilia and systemic symptoms; herpesvirus; outcome; treatment; viral reactivation; ATGA; antithyroglobulin antibody; ATPOA; antithyroperoxidase a
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; corticosteroid; drug hypersensitivity; drug-induced liver injury; ADR; adverse drug reaction; ALT; alanine aminotransferase; AST; aspartate aminotransferase; DiHS; drug-induced hypersensitivity syndrome; DRESS; drug reaction with eosinophilia and systemic
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; ADR; adverse drug reaction; AED; antiepileptic drug; AHS; Alpers-Huttenlocher syndrome; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CYP; cytochrome p450; DRESS; drug reaction with eos
Successful Intravenous Immunoglobulin Treatment in Pediatric Severe DRESS Syndrome
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; DRESS syndrome; Pediatric; Intravenous immunoglobulins; DRESS; Drug reaction with eosinophilia and systemic symptoms; EBV; Epstein-Barr virus; HHV-6; Human herpesvirus-6; IVIG; Intravenous immunoglobulin; TARC; Thymus and activation-regulated chemokine;
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: Case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; amlodipine; drug reaction; drug reaction with eosinophilia and systemic symptoms syndrome; perindopril; renal impairment; DRESS; drug reaction with eosinophilia and systemic symptoms; RegiSCAR; Registry of Severe Cutaneous Adverse Reactions;
The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Drug eruption; Glasgow prognostic score (GPS); Systemic inflammatory response syndrome (SIRS); Neutrophil to lymphocyte ratio (NLR); Thymus and activation-regulated chemokine (TARC); TARC; Thymus and activation-regulated chemokine; DIHS; drug-induced hype
The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Antibiotic allergy; Delayed hypersensitivity; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms; AA; Antibiotic-associated; AGEP; Acute generalized exanthematous pustulosis; DRESS; Drug reaction wi
The HLA-B*15:02 polymorphism and Tegretol®-induced serious cutaneous reactions in epilepsy: An updated systematic review and meta-analysis
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; ADRs; adverse drug reactions; cADRs; cutaneous adverse drug reactions; CBZ; carbamazepine; CI; confidence interval; DNA; deoxyribonucleic acid; DRESS; drug reaction with eosinophilia and systemic symptoms; GABRA1; gamma-aminobutyric acid type A receptor a
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Stevens-Johnson; Toxic epidermal necrolysis; HLA; Networks; Pharmacogenomics; Pharmacovigilance; Electronic health record; T cells; Granulysin; ADR; Adverse drug reaction; AMT; Amniotic membrane transplantation; BSA; Body surface area; CPNDS; Canadian Pha
The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; CTLs; cytotoxic T cells; DRESS; drug reaction with eosinophilia and systemic symptoms; EBV; Epstein-Barr virus; ELISpot; enzyme-linked immunospot assay; HHV; human herpesvirus; LAT; lymphocyte activation test; MPE; maculopapular eruption; PBMC; peripheral
Drug reaction with eosinophilia and systemic symptoms (DRESS) successfully treated with tumor necrosis factor-α inhibitor
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Drug reaction with eosinophilia and systemic symptoms; erythematous maculopapular rash; lithium carbonate; recombinant human TNF receptor-IgG fusion protein; treatment; tumor necrosis factor-α inhibitor; DRESS; drug reaction with eosinophilia and systemi
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; AED; antiepileptic drug; ALT; alanine aminotransferase; CBZ; carbamazepine; CI; confidence interval; DRESS; drug reaction with eosinophilia and systemic symptoms; ESL; eslicarbazepine acetate; GCP; Good Clinical Practice; mITT; modified intent-to-treat; M
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Phenytoin (PubChem CID: 1775); Lamotrigine (PubChem CID: 3878); Carbamazepine (PubChem CID: 2554); Phenobarbital (PubChem CID: 4763); Severe cutaneous adverse drug reactions; Stevens-Johnson syndrome; Toxic epidermal necrolysis; Drug reaction with eosinop
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Adverse drug reaction; Drug hypersensitivity; Drug-induced hypersensitivity syndrome; Eosinophil; HHV-6; ALT; alanine aminotransferase; AKI; acute kidney injury; CKD; chronic kidney disease; DRESS; drug reaction with eosinophilia and systemic symptoms; HA
Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS)
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; DRESS; drug reaction with eosinophilia and systemic symptoms; SJS; Steven-Johnson syndrome; TEN; toxic epidermal necrolysis; AGEP; acute generalised exanthematous pustulosis; RegiSCAR; European registry of severe cutaneous adverse reactions; NSAIDs; non
Impact of the HLA-B*58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; AUC; area under the curve; BSA; body surface area; cADR; cutaneous adverse drug reaction; CI; confidence interval; CKD; chronic kidney disease; DRESS; drug reaction with eosinophilia and systemic symptoms; eGFR; estimated glomerular filtration rate; HLA;
Drug reaction with eosinophilia and systemic symptoms during primary Epstein–Barr virus infection
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; acetaminophen; cefditoren–pivoxil; drug reaction with eosinophilia and systemic symptoms; Epstein–Barr virus; lymphocyte transformation test
Reviews and feature articleNew approaches for predicting T cell-mediated drug reactions: AÂ role for inducible and potentially preventable autoimmunity
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; T cell; adverse drug reaction; autoimmunity; ADR; Adverse drug reaction; DILI; Drug-induced liver disease; DRESS; Drug reaction with eosinophilia and systemic symptoms; GAD; Glutamic acid decarboxylase; OR; Odds ratio; SJS; Stevens-Johnson syndrome; SLE;
Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Lamotrigine; Antiepileptic drugs; Drug-induced hypersensitivity syndrome; Drug reaction with eosinophilia and systemic symptoms; Anticonvulsant hypersensitivity syndrome
Therapeutic management of DRESS: A retrospective study of 38 cases
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; drug-induced hypersensitivity syndrome; drug reaction with eosinophilia and systemic symptoms; severe cutaneous adverse reactions; systemic corticosteroids treatment; therapeutic management; topical steroids
Liver injury in patients with DRESS: A clinical study of 72 cases
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; drug-induced hypersensitivity syndrome; drug reaction with eosinophilia and systemic symptoms; drug eruption; interface change; liver injuryAEDs, antiepileptic drugs; Allopurinol-DRESS, allopurinol-induced drug reaction with eosinophilia and systemic symp
Research ArticleSafety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; HCV; hepatitis C virus; DAAs; direct-acting antiviral agents; PegIFNα; pegylated interferon alfa; AE; adverse event; SAE; serious adverse event; SVR; sustained virologic response; DRESS; drug reaction with eosinophilia and systemic symptoms; Hepatitis C;
Reviews and feature articleEvolving models of the immunopathogenesis of TÂ cell-mediated drug allergy: The role of host, pathogens, and drug response
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Abacavir; adverse drug reaction; allopurinol; altered peptide; carbamazepine; drug reaction with eosinophilia and systemic symptoms; hapten; heterologous immunity; human herpesvirus; human leukocyte antigen; major histocompatibility complex; p-i; pharmaco
Continuing medical educationDRESS syndrome: Part II. Management and therapeutics
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; AGEP; acute generalize exanthematous pustulosis; CMV; cytomegalovirus; DRESS; drug reaction with eosinophilia and systemic symptoms; EBV; Epstein-Barr virus; HHV-6; human herpesvirus-6; IVIG; intravenous immunoglobulin; LTT; lymphocyte transformation te
Long-term outcome of patients with severe cutaneous adverse reactions
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; drug eruption; drug-induced hypersensitivity syndrome; drug reaction with eosinophilia and systemic symptoms; sequela; Stevens-Johnson syndrome; toxic epidermal necrolysis
Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; autoimmune diseases; drug-induced hypersensitivity syndrome; drug reaction with eosinophilia and systemic symptoms; sequelaeAIHA, autoimmune hemolytic anemia; AITD, autoimmune thyroid disease; DM, diabetes mellitus; DRESS, drug reaction with eosinophilia
Serious Adverse Drug Reactions in Older Adults Notified to Pharmacovigilance
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; serious adverse reaction; drug; elderly; pharmacovigilance; effet indésirable grave; médicament; sujet âgé; pharmacovigilance; ADRs; adverse drug reactions; ATB; antibiotics; DRESS syndrome; drug reaction with eosinophilia and systemic symptoms; NSAID
Human Herpesviruses 6, 7, and 8 From a Dermatologic Perspective
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; CMV; Cytomegalovirus; DIHS; drug-induced hypersensitivity syndrome; DRESS; drug reaction with eosinophilia and systemic symptoms; HHV; human herpesvirus; KS; Kaposi sarcoma;
Drug hypersensitivity: Pharmacogenetics and clinical syndromes
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Drug hypersensitivity; drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity syndrome; Stevens-Johnson syndrome/toxic epidermal necrolysis; pharmacogenetics; severe cutaneous adverse reaction; abacavir; nevirapine; carbamaze
Skin Testing in Delayed Reactions to Drugs
Keywords: واکنش دارویی با ائوزینوفیلیا و نشانه های سیستمیک; Maculopapular rash; Acute generalized exanthematous pustulosis; Drug reaction with eosinophilia and systemic symptoms; Toxic epidermal necrolysis (TEN); Drug patch tests; Intradermal tests; Antibiotics; Corticosteroids